反义和 RNAi 治疗市场规模、份额及 2025-2031 年预测
Antisense and RNAi Therapeutics Market Report Analysis
Antisense and RNAi Therapeutics Market
-
CAGR (2025 - 2031)7.50% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Alnylam Pharmaceuticals
- Benitec Biopharma Ltd.
- Quark Pharmaceuticals
- Ionis Pharmaceuticals
- Astellas Pharma Inc
- Marina Biosciences
- Sanofi S
- Dicerna Pharmaceuticals
- Tekmira Pharmaceuticals
Regional Overview
- 北美
- 欧洲
- 亚太地区
- 南美洲和中美洲
- 中东和非洲
Market Segmentation
By 类型
- RNA干扰
- 反义RNA
By 给药途径
- 肺部给药
- 静脉注射
- 皮内注射
- 腹膜内注射
- 局部给药
- 其他
By 应用
- 传染病
- 心血管疾病
- 癌症
- 神经系统疾病等
By 地理
- 北美洲
- 欧洲
- 亚太地区
- 南美洲和中美洲
- 中东和非洲
Get Free Sample For